These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3828558)

  • 21. Strategies to identify or prevent drug resistance in cancer. A panel discussion.
    McGuire WL; Goldie JH; Salmon SE; Ling V
    Breast Cancer Res Treat; 1985; 5(3):257-68. PubMed ID: 4027394
    [No Abstract]   [Full Text] [Related]  

  • 22. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cancer stem cell gamble.
    Kaiser J
    Science; 2015 Jan; 347(6219):226-9. PubMed ID: 25593170
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Targeting tumor microenvironment heterogeneity.
    Hida K; Ishii G
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):139. PubMed ID: 27018072
    [No Abstract]   [Full Text] [Related]  

  • 25. A model for tumor response to chemotherapy: an integration of the stem cell and somatic mutation hypotheses.
    Goldie JH; Coldman AJ
    Cancer Invest; 1985; 3(6):553-64. PubMed ID: 3910195
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer stem cells: an approach to identify newer therapeutic targets.
    Srivastava S; Krishna S
    J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clonogenic cells in human tumors and the sensitivity to chemotherapy].
    Potapov SL; Korman DB
    Eksp Onkol; 1986; 8(1):7-12. PubMed ID: 3512239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory models: some historical perspective.
    Skipper HE
    Cancer Treat Rep; 1986 Jan; 70(1):3-7. PubMed ID: 3943114
    [No Abstract]   [Full Text] [Related]  

  • 29. An alternative to the magic bullet paradigm for specific cancer therapy.
    Moolten FL
    Med Hypotheses; 1987 Sep; 24(1):43-51. PubMed ID: 3670131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells targeting agents--a review.
    Shi AM; Tao ZQ; Li H; Wang YQ; Zhao J
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4064-7. PubMed ID: 26592827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental chemotherapy and concepts related to the cell cycle.
    Tannock IF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb; 49(2):335-55. PubMed ID: 3510996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theoretical considerations regarding the early use of adjuvant chemotherapy.
    Goldie JH; Coldman AJ
    Recent Results Cancer Res; 1986; 103():30-5. PubMed ID: 3738195
    [No Abstract]   [Full Text] [Related]  

  • 35. Companies hope for rare win with cancer stem cell therapies.
    Azvolinsky A
    Nat Med; 2012 Apr; 18(4):474. PubMed ID: 22481389
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical implications of tumor-cell heterogeneity.
    Schnipper L
    N Engl J Med; 1986 May; 314(22):1423-31. PubMed ID: 3517651
    [No Abstract]   [Full Text] [Related]  

  • 37. Q&A: John Dick on stem cells and cancer.
    Dick J
    Cancer Discov; 2013 Feb; 3(2):131. PubMed ID: 23400460
    [No Abstract]   [Full Text] [Related]  

  • 38. [Multidrug resistance].
    Baccarani M
    Haematologica; 1991 Jun; 76 Suppl 3():145-9. PubMed ID: 1684337
    [No Abstract]   [Full Text] [Related]  

  • 39. Numerical simulation of a stochastic model for cancerous cells submitted to chemotherapy.
    Abundo M; Rossi C
    J Math Biol; 1989; 27(1):81-90. PubMed ID: 2708919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second IASLC Workshop on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Biological basis of combined therapy.
    Souhami RL; Brodin O; Duchesne G; Goldie J; Green M; Kies M; Mattson K; Mulshine J; Saijo N; Saunders M
    Lung Cancer; 1994 Mar; 10 Suppl 1():S3-5. PubMed ID: 8087524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.